MetLife Expands Asset Management With $6B Acquisition From Mesirow

09.01.25 16:00 Uhr

Werte in diesem Artikel
Aktien

80,97 EUR 0,23 EUR 0,28%

Indizes

PKT PKT

16.447,9 PKT 124,0 PKT 0,76%

2.903,3 PKT 1,8 PKT 0,06%

5.918,3 PKT 9,2 PKT 0,16%

MetLife, Inc. MET announced that MetLife Investment Management (“MIM”) agreed to acquire three investment teams from Mesirow — a prominent employee-owned financial services firm, adding $6 billion in assets under management to its portfolio.This acquisition aligns with MetLife’s New Frontier strategy to expand its asset management capabilities and underscores MIM’s commitment to providing comprehensive investment solutions. The addition of high-yield, strategic fixed-income and small-cap equity teams enhances MIM’s existing offerings and expertise in higher-yield strategies. With this acquisition, MIM strengthens its competitive edge in the institutional investment management sector.The move also complements MIM’s broader initiative to develop its leveraged finance platform. By integrating Mesirow's high-yield and bank loan strategies, MIM can offer a diversified range of products tailored to various risk-return profiles. This acquisition follows MIM’s recent announcement of acquiring assets from PineBridge Investments, signaling its commitment to sustained growth through expansion.The transaction, which included 20 seasoned investment professionals from Mesirow, enhances MIM’s talent pool — a key driver for delivering strong investment performance. The added expertise, combined with MIM’s robust distribution network, positions the firm to capture growth opportunities in institutional asset management.Asset management companies face intense competition due to evolving client needs and increased regulations, pushing them to strengthen their positions through expansion. Moves like this are expected to enhance its product offerings and attract a large customer base.MET’s Price PerformanceThe company’s shares have gained 15.6% in the past six months, outperforming 3.2% growth of the industry. Image Source: Zacks Investment Research MetLife’s Zacks RankMET currently has a Zacks Rank #3 (Hold).Stocks to ConsiderSome better-ranked stocks in the insurance space are United Fire Group, Inc. UFCS, CNO Financial Group, Inc. CNO and Primerica, Inc. PRI. United Fire Group and CNO Financial sport a Zacks Rank #1 (Strong Buy) at present, and Primerica carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The bottom line of United Fire Group outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 58.79%.The Zacks Consensus Estimate for UFCS’s 2024 earnings is pegged at $1.84 per share. A loss of $1.22 per share was incurred in the prior year. The consensus mark for revenues indicates 13.9% year-over-year growth. The consensus mark for United Fire Group’s 2024 earnings has moved 67.3% north in the past 60 days.The bottom line of CNO Financial outpaced estimates in three of the trailing four quarters and missed once, the average surprise being 24.51%.The Zacks Consensus Estimate for CNO’s 2024 earnings indicates 20.7% year-over-year growth. The Zacks Consensus estimate for 2024 revenues is pegged at $3.7 billion. The consensus mark for CNO Financial’s 2024 earnings has moved 2.8% north in the past 60 days.Primerica’s earnings outpaced estimates in two of the trailing four quarters and missed the mark twice, the average surprise being 4.89%.The Zacks Consensus Estimate for PRI’s 2024 earnings indicates 20.2% year-over-year growth, whereas the same for revenues implies an improvement of 6.9%. The consensus mark for Primerica’s 2024 earnings has moved 6.7% north in the past 60 days.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CNO Financial Group, Inc. (CNO): Free Stock Analysis Report MetLife, Inc. (MET): Free Stock Analysis Report Primerica, Inc. (PRI): Free Stock Analysis Report United Fire Group, Inc (UFCS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"